SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.170+3.5%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: old 'n cranky who wrote (9922)2/26/2018 8:49:01 AM
From: donpat  Read Replies (1) of 12873
 
Looks like normal business to me.

Mulligans are not involved as I see it.

further modeling and analysis be performed incorporating additional assumptions that reflect our situation more closely than in the model that was presented."
"Model that was presented" - by whom to whom? I have no idea, somebody in control obviously, BOD, Diwan, Seymour, all or one or more. Sounds like something changed!! What, why; whatever it looks like Myers is continuing so it ain't her doing; she performed well enough to do the rethink. Perhaps Seymour leaving occasioned the new review. Perhaps the entry of Glaxo and/or BMS into the picture?

Something quite juicy IMHHO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News